Prevalence of Toxoplasma Gondii and Toxocara Canis Antibodies among Owners of Dogs and Cats in Ekiti State Nigeria
Main Article Content
Abstract
Zoonoses are still a serious public health concern since the number of homeless animals, particularly dogs and cats, is increasing. As the causative agents of human toxoplasmosis and toxocariasis, respectively, Toxoplasma gondii and Toxocara canis are significant zoonotic agents from an epidemiological perspective. We have ascertained the seroprevalence of T. gondii and T. canis antibodies among dog and cat owners by a cross-sectional study. Between May and July of 2024, serum samples were taken from 185 owners in Ekiti State, Nigeria. Using an enzyme-linked immunosorbent test (ELISA), the pet owners' sera were collected. The seroprevalence of IgM and IgG antibodies for T. gondii was 3.8% and 9.4%, respectively, in dogs, whereas the IgG antibody seroprevalence for T. canis was 7.5%. Additionally, our seroprevalence findings indicate that dog owners may be more susceptible to contracting T. gondii and T. canis infections, especially if they are female owners. Dog owners in Ekiti State, Nigeria, have significant levels of anti-T. gondii and anti-toxocara antibodies, suggesting a possible zoonotic risk. In order to mitigate the risk of T. gondii and T. canis environmental contamination, it is recommended that dogs and cats have appropriate deworming, be leashed, and have their waste cleaned up. These steps should aid in preventing the morbidity that these two different but extremely adaptable parasites produce in humans.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Araújo, A.C., Marcos Marreiro Villela1, Ângela Sena-Lopes, Nara Amélia da Rosa Farias, Laura Maria Jorge de Faria, Luciana Farias da Costa Avila, Maria Elisabeth Aires Berne, Sibele Borsuk (2018). Seroprevalence of Toxoplasma gondii and Toxocara canis in a human rural population of Southern Rio Grande do Sul. Rev Inst Med Trop São Paulo.;60:e28
II. Hotez, P.J., Alvarado, M. and Basáñez, M-G (2010). The global burden of disease study : Interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis 2014;8:e2865
III. Dubey JP, Murata FHA, Cerqueira-Cézar CK, Kwok OCH, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology. (2021) 148:1406–1416
IV. Rostami A, Riahi SM, Holland CV, Taghipour A, Khalili-Fomeshi M, Fakhri Y, et al.
Seroprevalence estimates for toxocariasis in people worldwide: A systematic review and
meta-analysis. PLoS Negl Trop Dis. (2019) 13:e0007809.doi:10.1371/journal.pntd.0007809
Rahmanian V, Rahmanian K, Jahromi A, Bokaie S. Seroprevalence of Toxoplasma
gondii infection: An umbrella review of updated systematic reviews and meta-analyses.
J Fam Med Prim Care. (2020) 9:3848–55.
V. Khademvatan, S., Rahim, F., Tavalla,M., Abdizadeh, R. and Hashemitabar, M. (2013). “PCR-based molecular characterization of Toxocara spp. using feces of stray cats: a study from Southwest Iran,” PLoS ONE, vol. 8, no. 6,
VI. Jones, J.L., Kruszon-Moran, D., Won, K., Wilson, M. and Schantz, P.M.. (2008). Toxoplasma gondii and Toxocara spp. Co-infection, Am. J. Trop. Med. Hyg., 78(1)35–39
VII. Bowman, D.D. (2009). In: Bowman DD, editor. Georgis’ Parasitology for Veterinarians. 9th ed. Philadelphia: Saunders Elsevier; p. 451.
VIII. Dubey, J.P. and Beattie, C.P. (2010). Toxoplasmosis of animals and humans. 2nd edition. Boca Raton, Florida: CRC Press Inc.; 2010; 1–313.
IX. Montoya, J.G. and Liesenfeld, O. (2004). Toxoplasmosis. Lancet.;363:1965–76.
X. Dantas-Torres, F. and Otranto, D. (2014). Dogs, cats, parasites, and humans in Brazil: opening the black box. Parasit Vectors;7:22.
XI. McConnell, A.R., Brown, C.M., Shoda, T.M., Stayton, L.E. and Martin, C.E. (2011). Friends with benefits: on the positive consequences of pet ownership. J Pers Soc Psychol.;101:1239–52
XII. Jones JL, Dargelas V, Roberts J, Press C, Remington JS, Montoya JG. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. 2009;49:878–84.
XIII. Elsheikha HM. Congenital toxoplasmosis: priorities for further health promotion action. Public Health. 2008;122:335–53.
XIV. Schares G, Pantchev N, Barutzki D, Heydorn AO, Bauer C, Conraths FJ. Oocysts of Neospora caninum, Hammondia heydorni, Toxoplasma gondii and Hammondia hammondi in faeces collected from dogs in Germany. Int J Parasitol. 2005;35:1525–37.
XV. Wei, C., Hany, M. E., Na Z., Peng, P., Si-Yuan, Q., Qing-Feng, M. and Ai-Dong, Q. (2018). Prevalence of antibodies against Toxoplasma gondii in pets and their owners in Shandong province, Eastern China BMC Infectious Diseases; 18:430
XVI. Nissapatorn, V., Lee, C., Quek, K. F., Leong, C. L. and Mahmud, R. (2004). “Toxoplasmosis in HIV/AIDS patients: a current situation,” Japanese Journal of Infectious Diseases, vol. 57, no. 4, pp. 160–165.
XVII. Smith, H., Holland, C., Taylor, M., Magnaval, J.F., Schantz, P. & Maizels, R. (2009). How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitology 25, 182–188.
XVIII. Fakhri, Y. Gasser, R. and Rostami, A. (2018). Toxocara eggs in public places worldwide: A systematic review and meta-analysis. Environ Pollut.; 242: 1467–1475.
XIX. Torrey, E.F. and Yolken, R.H. (2013). Toxoplasma oocysts as a public health problem. Trends Parasitol; 29: 380–384.
XX. Goldstein EJ, Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008; 47: 554–566.
XXI. Smith H, Holland C, Taylor M, Magnaval J, Schantz P, Maizels R. How common is human toxocariasis? Towards standardizing our knowledge. Trends Parasitol 2009; 25:182–188
XXII. Furtado JM, Smith JR, Belfort R, Gattey D, Winthrop KL. Toxoplasmosis: a global threat. J Glob Infect Dis. (2011) 3:281–4.
XXIII. Henriquez S.A., Brett R., Alexander J., Pratt J. and Roberts C.W. (2009). Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation, 16(2): 122-133.
XXIV. Xiao, Y., Yin, J., Xiang, M., Hao, L. and Lu, H. (2010). Seroepidemiology of human Toxoplasma gondii infection in china. BMC Infect Dis. 10:4
XXV. Rahmanian, V., Rahmanian, K., Jaromi, A.S. and Bokaie, S. (2020). Seroprevalence of Toxoplasma gondii infection: An Umbrella Review of updated systemic reviews and meta-analysis, 9(8), 3848-3855
XXVI. Silveira, C., Vallochi, A.L., Da Silva U.R., Muccioli, C., Holland, G.N. and Nussenblatt, R. (2011). Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol, 95, 396-400
XXVII. Jones J.L., Kruszon-Moran D., Wilson M., McQuillan G., Navin, T. and Mc Auley, J.B. (2001). Toxoplasma gondii infection in the United States: seroprevalence and risk factors. AM. J. Epidemiol 154, 357-365
XXVIII. Kamani, J., Mani, A.U., Egwu, G.O. and Kumshe, H.A. (2009). Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno State, Nigeria. Ann Trop Med Parasitol, 103 (4)317-321
XXIX. Henriquez, S. A., Brett, R., Alexander, J. Pratt, J. and Roberts, C.W. (2009). Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 16 (2) 122-133
XXX. Liu Q , Wei F , Gao S , Jiang L , Lian H , Yuan B , Yuan Z , Xia Z , Liu B , Xu X , Zhu XQ ,
(2009) . Toxoplasma gondii infection in pregnant women in China . Trans R Soc Trop Med Hyg 103:162 – 166.
XXXI. Subrata, I M., Suryadhi, N. T., Mantik-Astawa, N., Damriyasa, I M. (2015). Epidemiological and Molecular Analysis of Toxoplasma gondii in Faecal Samples of Cats Obtained from House of Maternal in Bali. Bali Medical Journal, 4 (2) 68-75
XXXII. Olusi T, Gross U, Ajayi J. (1996). High prevalence of toxoplasmosis during pregnancy in Nigeria.
Scand J Infect Dis.;28(6): 645-6.
XXXIII. Samuel Agwu Ode Afusat Jagun Jubril, Benjamin Obukowho Emikpe (2021). Awareness and habits of Nigerians towards toxoplasmosis and risk factors, PAMJ - One Health.;4(15)
XXXIV. Prandota, J. (2010). “Neuropathological changes and clinical features of autism spectrum disorder participants are similar to that reported in congenital and chronic cerebral toxoplasmosis in humans and mice,” Research in Autism Spectrum Disorders, vol. 4, no. 2, pp. 103–118.